Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective

Sponsor
PeriPharm
Study ID
NCT07323394
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • No Intervention: Observational Cohort — OTHER
    No specific intervention is assess in this study. Observational cohort.

Study Details

This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.

Key Dates

First listed
Jan 7, 2026
Start date
Jan 31, 2026
Status verified
Jan 2026
Primary completion
Jun 30, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Caregiver of child with atopic dermatitis
    Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis

Primary Outcome Measure

To estimate work productivity loss in caregivers of children with mild or moderate atopic dermatitis. [ Time Frame: At recruitment ]

Central Contacts

Find similar trials

Nationwide
Atopic dermatitis / eczema trialsDermatology trialsRheumatology trialsAutoimmune disease trials

Related Studies